Oncolytic therapy was first introduced in the field of oncology a decade ago. Recently, advancements have been made in oncolytic therapy, with the promise of potentially transforming the melanoma treatment landscape. In these two 1.5-hour JADPRO Live classes on October 23, 2025, participants will have the opportunity to gain hands-on training experience in injecting different types of melanoma lesions. This training opportunity has been designed to complement text-based and video content to support advanced practice providers seeking credentialing for intralesional therapy or looking to update their knowledge base and skills.
Are you interested in participating in this exclusive training opportunity? If you are involved in the care of patients with melanoma and are planning to attend JADPRO Live 2025, please fill out this interest form. We will contact you individually about availability for these exclusive sessions.
This activity is intended for oncology care providers (including physicians, advanced practice providers, nurses, pharmacists, and other healthcare providers) who care for patients with melanoma and non-melanoma skin cancer.
Lisa Kottschade, APRN, MSN, CNP, FAPO
Nurse Practitioner
Associate Professor of Oncology
Mayo Clinic College of Medicine
Rochester, Minnesota
Suzanne McGettigan, MSN CRNP AOCN®
Oncology Nurse Practitioner
Senior Clinical Manager
Division of Hematology-Oncology
Abramson Cancer Center
University of Pennsylvania Health System
Philadelphia, Pennsylvania
Margaret "Meg" Leddy, PA-C, MMSc
Physician Assistant – Oncology
Duke Cancer Center
Durham, North Carolina
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners); Terranova Medica, LLC; Advanced Practitioner Society for Hematology and Oncology (APSHO); and Integrita Healthcare Education Foundation. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Partners designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours. Designated for 1.5 contact hours of pharmacotherapy credit for Advanced Practice Registered Nurses.
Partners designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
Type of Activity: Knowledge
There is no charge for this activity.
Jointly provided by Partners for Advancing Clinical Education; Terranova Medica, LLC; APSHO; and Integrita Healthcare Foundation.
This activity is supported by an independent educational grant from Replimune.
For further information, contact Tom Davis by email (tdavis@terranovamedica.com).
Copyright © 2025 Partners for Advancing Clinical Education, APSHO, Integrita, and Terranova Medica.
